Insider filing · RAPP
James Healy
Director
profile →
Rapport Therapeutics, Inc.
RAPP · Healthcare · 38 filings in 24 months
ticker →
James Healy bought $20.3M of Rapport Therapeutics (RAPP)
Executed Oct 28, disclosed Oct 30, 2 days later.
Value, as filed
$20.3M
965,708 sh across 3 lots
Executed
Oct 28
the trade date, as filed
Disclosed
Oct 30
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
not yet measured
Not yet measured: the 21-session window has not closed, or the prices around it are not on record.
The filer
JHJames Healy (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Rapport Therapeutics, Inc. (RAPP). The largest single filing was $20.3M of RAPP (965,708 sh across 3 lots, as filed), executed Oct 28. The median gap between execution and disclosure was 2 days.
The name
RAPPHealthcare · Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transfo…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→